Healthcare - Sector
NKTR is currently covered by 9 analysts with an average price target of $148.8. This is a potential upside of $116.26 (357.28%) from yesterday's end of day stock price of $32.54.
Nektar Therapeutics's activity chart (see below) currently has 175 price targets and 193 ratings on display. The stock rating distribution of NKTR is 80.77% BUY and 19.23% HOLD.
Analysts' price targets on this stock were met 43.12% of the time, taking 224.55 days on average.
Highest price target for NKTR is $192, Lowest price target is $50, average price target is $148.8.
Most recent stock forecast was given by JULIAN HARRISON from BTIG on 09-Oct-2026. First documented stock forecast 28-Jul-2014.
Currently out of the existing stock ratings of NKTR, 21 are a BUY (80.77%), 5 are a HOLD (19.23%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Sep-2024
$178
$140.73 (377.60%)
$178
1 months 11 days ago
(09-Oct-2026)
2/10 (20%)
$136.83 (332.35%)
257
Buy Since 10-Dec-2024
$185
$147.73 (396.38%)
$185
1 months 18 days ago
(02-Oct-2026)
2/7 (28.57%)
$141.42 (324.51%)
420
Hold Since 24-Mar-2026
$50
$12.73 (34.16%)
$80
1 months 28 days ago
(23-Sep-2026)
3/4 (75%)
$-7.66 (-13.28%)
4
Hold Since 21-Aug-2026
$65
$27.73 (74.40%)
2 months 30 days ago
(21-Aug-2026)
6/11 (54.55%)
$-9.02 (-12.19%)
107
Buy Since 04-Nov-2024
$192
$154.73 (415.16%)
$105
6 months 12 days ago
(08-May-2026)
1/3 (33.33%)
$110.11 (134.46%)
532
What is NKTR (Nektar Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on NKTR (Nektar Therapeutics)?
Which analyst has the most public recommendations on NKTR (Nektar Therapeutics)?
Which analyst is the currently most bullish on NKTR (Nektar Therapeutics)?
Which analyst is the currently most reserved on NKTR (Nektar Therapeutics)?